Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

SEPRACOR FILES 3.25 MILLION-SHARE IPO

Aug. 9, 1991

ANALYST IMPRESSED WITH GI's M-CSF

Aug. 9, 1991

TWO IPOs CLOSE AT TOP PRICES

Aug. 8, 1991

ANALYST BASHES XOMA AND CENTOCOR

Aug. 8, 1991

LIDAK GETS PATENT, SBIR FOR ANTI-VIRAL

Aug. 8, 1991

ANERGEN FILES FOR 1.75-MILLION-SHARE IPO

Aug. 8, 1991

CISTRON REGAINS IL-1 BETA RIGHTS

Aug. 8, 1991

KININ BLOCKERS MAY RELIEVE PAIN

Aug. 7, 1991

BAY AREA LAW FIRMS JOIN FORCES

Aug. 7, 1991

NEUROGEN RAISES $7.7 MILLION IN OFFERING

Aug. 7, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...